Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
11 hedge funds and large institutions have $1.16M invested in Genetic Technologies Ltd. in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
10% more funds holding
Funds holding: 10 → 11 (+1)
10% more capital invested
Capital invested by funds: $1.06M → $1.16M (+$103K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$180K |
| 2 |
Jane Street
New York
|
+$49K |
| 3 |
Morgan Stanley
New York
|
+$33.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.79K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$908 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$268K |
| 2 |
Renaissance Technologies
New York
|
-$167K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$40K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$17.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $851K | -$167K | -3,315 | -17% |
|
|
OAM
2
Oxford Asset Management
Oxford,
United Kingdom
| $193K | +$180K | +3,560 | New |
|
|
3
Jane Street
New York
| $52K | +$49K | +972 | New |
|
|
4
Morgan Stanley
New York
| $47K | +$33.7K | +668 | +308% |
|
|
5
UBS Group
Zurich,
Switzerland
| $10K | +$9.79K | +194 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | – | – | – |
|
|
7
Creative Planning
Overland Park,
Kansas
| $1K | -$17.9K | -355 | -93% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | -$7.62K | -151 | -90% |
|
|
AIA
9
Allegis Investment Advisors
Idaho Falls,
Idaho
| $1K | +$1.41K | +28 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| – | -$268K | -7,540 | Closed |
|
|
VKH
11
Virtu KCG Holdings
New York
| – | -$40K | -1,127 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$23K | -636 | Closed |
|
13
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$13K | -390 | Closed |
|
14
Citigroup
New York
| – | +$303 | +6 | +300% |
|
|
15
Simplex Trading
Chicago,
Illinois
| – | +$908 | +18 | New |
|
GENE Hedge Fund Activity: Q4 2015 in Review
11 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2015, worth a combined $1.16M — up 9.7% from $1.06M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GENE positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Oxford Asset Management, opening a new position worth an estimated $180K. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $268K sold.
- 11 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2015, up from 10 in Q3 2015.
- Funds reported $1.16M of Genetic Technologies Ltd. stock for Q4 2015, up 9.7% quarter-over-quarter.
- 5 funds opened new Genetic Technologies Ltd. positions in Q4 2015 and 4 closed out, a net change of +1 holder.
- The largest Genetic Technologies Ltd. buyer in Q4 2015 was Oxford Asset Management, an estimated $180K added.
- The largest Genetic Technologies Ltd. seller in Q4 2015 was Wolverine Asset Management, an estimated $268K sold.
Based on aggregated 13F filings for Q4 2015.